Yüklüyor......
Potential benefit of dolutegravir once daily: efficacy and safety
The viral integrase enzyme has recently emerged as a primary alternative target to block HIV-1 replication, and integrase inhibitors are considered a pivotal new class of antiretroviral drugs. Dolutegravir is an investigational next-generation integrase inhibitor showing some novel and intriguing ch...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3570074/ https://ncbi.nlm.nih.gov/pubmed/23413040 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/HIV.S27765 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|